Ly, A., & Stamatatos, L. (2000). V2 Loop Glycosylation of the Human Immunodeficiency Virus Type 1 SF162 Envelope Facilitates Interaction of This Protein with CD4 and CCR5 Receptors and Protects the Virus from Neutralization by Anti-V3 Loop and Anti-CD4 Binding Site Antibodies. American Society for Microbiology.

Ly, Amy, und Leonidas Stamatatos. V2 Loop Glycosylation of the Human Immunodeficiency Virus Type 1 SF162 Envelope Facilitates Interaction of This Protein With CD4 and CCR5 Receptors and Protects the Virus From Neutralization By Anti-V3 Loop and Anti-CD4 Binding Site Antibodies. American Society for Microbiology, 2000.

Ly, Amy, und Leonidas Stamatatos. V2 Loop Glycosylation of the Human Immunodeficiency Virus Type 1 SF162 Envelope Facilitates Interaction of This Protein With CD4 and CCR5 Receptors and Protects the Virus From Neutralization By Anti-V3 Loop and Anti-CD4 Binding Site Antibodies. American Society for Microbiology, 2000.